Come join others currently navigating treatment in our weekly Zoom Meetup! Register here: Tuesdays, 1pm ET.
Fill Out Your Profile to share more about you. Learn more...
Webinar: Corrective Breast Reconstruction: Getting the Results You Want Join us July 9, 2024 at 6pm ET. Register here.

Research With Immediate Impact at 2023 SABCS

Options

Research With Immediate Impact at 2023 SABCS

Dec 8, 2023

Dr. Matthew Goetz tells us about the research that will change the way he talks to his patients.

The 2023 San Antonio Breast Cancer Symposium featured five days of research presentations, educational sessions, and advocacy meetings.

Dr. Matthew Goetz, noted breast cancer researcher at the Mayo Clinic, explained the top research presented that will make an immediate difference for people diagnosed with breast cancer.

Listen to the podcast to hear Dr. Goetz explain:

  • a study on inavolisib, a promising new treatment for advanced-stage, hormone receptor-positive breast cancer that’s stopped responded to tamoxifen or an aromatase inhibitor
  • how the immunotherapy medicines Keytruda (chemical name: pembrolizumab) and Opdivo (chemical name: nivolumab) can be used to treat early-stage, triple-negative breast cancer
  • overall survival results from the MONARCH-3 study on Verzenio (chemical name: abemaciclib)
  • why overall survival is such an important study end point

Listen now or read the transcript.

Tagged: